Nabriva Therapeutics plc Depreciation & Amortization 2011-2026 | NBRV

Annual Depreciation & Amortization Nabriva Therapeutics plc

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
217 K	356 K	417 K	396 K	510 K	432 K	233 K	153 K	166 K	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
510 K	153 K	320 K

Quarterly Depreciation & Amortization Nabriva Therapeutics plc

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
21 K	-	192 K	-	78 K	-	270 K	-	99 K	-	315 K	209 K	103 K	-	162 K	245 K	125 K	-	391 K	262 K	133 K	-	295 K	149 K	76 K	-	172 K	99 K	45 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
391 K	21 K	172 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Akari Therapeutics, Plc AKTX	14 K	$ 5.26	2.7 %	$ 354 B	Britain
Aligos Therapeutics ALGS	930 K	$ 6.7	-12.53 %	$ 66.2 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Alnylam Pharmaceuticals ALNY	55.7 M	$ 315.2	-1.54 %	$ 41.3 B	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Amphastar Pharmaceuticals AMPH	31.6 M	$ 22.46	2.98 %	$ 1.05 B	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.08	-	$ 5.07 M	Israel
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
BioXcel Therapeutics BTAI	300 K	$ 1.19	11.23 %	$ 14.5 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	1.27 M	$ 1.39	2.96 %	$ 357 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	548 K	$ 4.35	2.0 %	$ 465 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 24.45	1.07 %	$ 3.11 B	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Brainstorm Cell Therapeutics BCLI	199 K	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Cabaletta Bio CABA	1.65 M	$ 3.34	-5.26 %	$ 336 M	USA
Autolus Therapeutics plc AUTL	8.3 M	$ 1.64	1.86 %	$ 436 M	Britain
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	28 M	-	-	$ 546 M	USA
Celldex Therapeutics CLDX	3.38 M	$ 35.15	3.81 %	$ 2.33 B	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Cidara Therapeutics CDTX	154 K	-	-	$ 1.41 B	USA
CymaBay Therapeutics CBAY	681 K	-	-	$ 3.45 B	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA